Antibiotics Special Issue: Challenges and Opportunities in Antibiotic Discovery and Development

  15 June 2020

Antimicrobial resistance (AMR) has received increasing global attention over the past decade. The lack of antibiotics in the clinical pipeline is a direct result of the discouraging financial incentives for their commercial development. This has led to a precarious situation where the widespread emergence of highly resistant strains could threaten the viability of the worldwide health system, as seen with the current COVID-19 crisis. While a number of nonantibiotic alternative antimicrobial approaches show interesting potential, it is difficult to see how they would displace the need for new antibiotics for the foreseeable future.

This special issue on antibiotics is a combination of viewpoints, perspectives, reviews, and original research manuscripts that provides a snapshot of the current state of affairs in antibiotic discovery and development. It is anchored by a set of 10 interrelated viewpoints and two perspectives from many of the world’s leading agencies and key opinion leaders with an interest in antimicrobial resistance.

Further reading: ACS Infectious Diseases
Author(s): Mark A. T. Blaskovich
Smart Innovations  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!